Welcome to LookChem.com Sign In|Join Free

CAS

  • or

17157-48-1

Post Buying Request

17157-48-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

17157-48-1 Usage

Uses

Bromoacetaldehyde can be used as an intermediate in pharmaceutical and chemical synthesis, mainly in laboratory research and development and chemical production processes.

Definition

ChEBI:2-Bromoacetaldehyde is an organobromine compound.

Synthesis

Preparation of Bromoacetaldehyde:1,4-dibromo-trans-2-butene(10g, 0.046 mol) was dissolved in dry CH2CI2 (100 ml) and cooled to -780℃ and ozone gas was bubbled until the blue color persisted (~30 min). A nitrogen stream was passed through the solution until the blue color disappeared, giving colorless solution. Triphenyl phosphine (12.9g, 0.046 mol) was added portion wise over a period EPO of 1 hr. The reaction mixture was brought to 0℃ and kept in the refrigerator for 15 hrs. The solvent (CH2CI2) was removed from the reaction mixture (without applying vacuum) and the thick residue was distilled at 400℃ under vacuum (1mm Hg), maintaining the temperature of the receiving flask at -780℃. (during distillation, special care was taken to maintain a cold water circulation (~0°C to - 50℃)). The bromoacetaldehyde(2.8g, yield = 50%) was obtained as a light yellow liquid.

Check Digit Verification of cas no

The CAS Registry Mumber 17157-48-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,7,1,5 and 7 respectively; the second part has 2 digits, 4 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 17157-48:
(7*1)+(6*7)+(5*1)+(4*5)+(3*7)+(2*4)+(1*8)=111
111 % 10 = 1
So 17157-48-1 is a valid CAS Registry Number.
InChI:InChI=1/C2H3BrO/c3-1-2-4/h2H,1H2

17157-48-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-bromoacetaldehyde

1.2 Other means of identification

Product number -
Other names bromoacetaldehyde

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:17157-48-1 SDS

17157-48-1Relevant articles and documents

The Energy Surface for Isomeric (1+) Ions: Further Experimental Evidence

Turecek, Frantisek,McLafferty, F. W.

, p. 608 - 611 (1983)

Mass spectra from collisionally activated dissociation (CAD) of (1+) ions, including isotopically labeled analogs, provide further information on the isomers O(1+)> (a), (b), (c) and (d).Our data generally support the recent conclusions from theory by Radom and coworkers and from experiment by Terlouw, Holmes and coworkers.Most acetyl-containing molecular ions form a ions in high purity only at low energies, consistent with isomerization of higher energy molecular ions to form the more stable enol which dissociates to b.Isomer d, prepared from (ClCH2)2CHOH, undergoes facile hydrogen scrambling, presumably through a degenerate 1,2-hydrogen shift.Theory suggests that c undegoes spontaneous isomerization to a and d; although (1+) ions from BrCH2CHO appear to consist of a and ca.15percent d, the latter are formed without substantial hydrogen scrambling.

Modification of adenine and cytosine derivatives with bromoacetaldehyde

Kayasuga,Hashimoto,Negishi,et al.

, p. 932 - 938 (1980)

-

Synthesis of 2-unsubstituted 1,3-selenazoles by cyclization of selenoformamide with α-bromocarbonyl compounds

Below, Harald,Pfeiffer, Wolf-Diethard,Geisler, Karlheinz,Saghyan, Ashot S.,Fischer, Christine,Langer, Peter

, p. 592 - 596 (2015)

2-Unsubstituted 1,3-selenazoles were prepared by cyclization of selenoformamide with α-bromoacetophenones. Parent 1,3-selenazole was prepared by cyclization of selenoformamide with α-bromoacetaldehyde.

Kinetic study of the self-reactions of the BrCH2CH2O2 and BrCH(CH3CH(CH3O2 radicals between 275 and 373 K

Villenave, Eric,Moisan, Sandy,Lesclaux, Robert

, p. 2470 - 2477 (2003)

A conventional flash photolysis technique was used to measure the self-reaction rate constants of the primary BrCH2CH2O2 (2-bromoethylperoxy) and secondary BrCH(CH3)CH(CH3)O2 (2-bromo-l-methylpropylperoxy) β-brominated peroxy radicals, at temperatures in the range of 275-373 K. The absolute UV absorption spectra of BrCH2CH2O2 and BrCH(CH3)CH(CH3)O2 were also measured and compared to those obtained previously for these radicals. The temperature dependence of the self-reaction rate constants provided the following Arrhenius expressions: k(BrCH2CH2O2 + BrCH2CH2O2) = (6.15+5.152.99) × 10-14 exp{(1247 ± 203) K/T} cm3 molecule-1 s-1 and k(BrCH(CH3)CH(CH3)O2 + BrCH(CH3)CH(CH3)O2) = (7.60+22.05-5.65) × 10-15 exp{(1305 ± 428) K/T} cm3 molecule-1 s-1, where the uncertainties represent 95% confidence limits associated with the statistical fitting procedure and include the contribution for the expanded uncertainties in the individual rate constant. These results confirm the enhancement of the peroxy radical self-reaction reactivity upon β-substitution, which is similar for Br, Cl, or OH substituents. Structure-activity relationships are proposed for self-reactions of β-substituted peroxy radicals.

Synthesis of Ketones by C?H Functionalization of Aldehydes with Boronic Acids under Transition-Metal-Free Conditions

Roscales, Silvia,Csáky, Aurelio G.

supporting information, p. 8728 - 8732 (2021/03/16)

A method for the synthesis of ketones from aldehydes and boronic acids via a transition-metal-free C?H functionalization reaction is reported. The method employs nitrosobenzene as a reagent to drive the simultaneous activation of the boronic acid as a boronate and the activation of the C?H bond of the aldehyde as an iminium species that triggers the key C?C bond-forming step via an intramolecular migration from boron to carbon. These findings constitute a practical, scalable, and operationally straightforward method for the synthesis of ketones.

Scaffold-Hopping Strategy on a Series of Proteasome Inhibitors Led to a Preclinical Candidate for the Treatment of Visceral Leishmaniasis

Thomas, Michael,Brand, Stephen,De Rycker, Manu,Zuccotto, Fabio,Lukac, Iva,Dodd, Peter G.,Ko, Eun-Jung,Manthri, Sujatha,McGonagle, Kate,Osuna-Cabello, Maria,Riley, Jennifer,Pont, Caterina,Simeons, Frederick,Stojanovski, Laste,Thomas, John,Thompson, Stephen,Viayna, Elisabet,Fiandor, Jose M.,Martin, Julio,Wyatt, Paul G.,Miles, Timothy J.,Read, Kevin D.,Marco, Maria,Gilbert, Ian H.

supporting information, p. 5905 - 5930 (2021/06/01)

There is an urgent need for new treatments for visceral leishmaniasis (VL), a parasitic infection which impacts heavily large areas of East Africa, Asia, and South America. We previously reported on the discovery of GSK3494245/DDD01305143 (1) as a preclinical candidate for VL and, herein, we report on the medicinal chemistry program that led to its identification. A hit from a phenotypic screen was optimized to give a compound with in vivo efficacy, which was hampered by poor solubility and genotoxicity. The work on the original scaffold failed to lead to developable compounds, so an extensive scaffold-hopping exercise involving medicinal chemistry design, in silico profiling, and subsequent synthesis was utilized, leading to the preclinical candidate. The compound was shown to act via proteasome inhibition, and we report on the modeling of different scaffolds into a cryo-EM structure and the impact this has on our understanding of the series' structure-activity relationships.

DOXOPHYLLINE DERIVATIVES

-

Page/Page column 6; 14, (2020/10/17)

Deuterated doxophylline compounds having the following formula (I), with an improved pharmacokinetic profile and improved activity, are described: Formula (I) wherein: R1 is protium (H) or deuterium (D), independently of each other, provided that at least one of R1 is deuterium (D), and a process for the preparation thereof. The preferred compounds comprise: 7-((1,3-dioxolan-2-yl) methyl-d3)-1,3 -dimethyl-1H-purine-2, 6 (3H,7H)-dione, 7-((1,3 -dioxolan-2-il) methyl-d4)-1,3-dimethyl-1H-purine-2, 6 (3H,7H)-dione, and 7-((1,3 -dioxolan-2-il) methyl-d7)-1,3-dimethyl-1H-purine-2, 6 (3H,7H)-dione.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 17157-48-1